Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PROVECTUS BIOPHARMACEUTICALS, INC. | CFO | 8% Unsecured Convertible Promissory Note due 2022 | $125K | Feb 28, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | Feb 28, 2024 | 1 | -$50K | 4 | Feb 29, 2024 | CFO |
PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | Feb 2, 2024 | 1 | -$25K | 4 | Feb 6, 2024 | CFO |
PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | Aug 16, 2021 | 1 | $200K | 4 | Aug 18, 2021 | CFO |
PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | Jun 17, 2021 | 3 | $0 | 4 | Jun 22, 2021 | CFO |